Joe G Hollyfield

Title: Joe G. Hollyfield: Inventor in Retinal Degeneration Research.

Introduction

Joe G. Hollyfield is an inventor associated with Shaker Heights, Ohio. His patent work includes research into retinal degeneration and age-related macular degeneration (AMD). He has been associated with Case Western Reserve University and The Cleveland Clinic Foundation. Hollyfield holds 4 patents.

Latest Patents

One of Hollyfield’s latest patents, “Mouse Model of Retinal Degeneration,” describes methods for producing non-human mammals with pathological characteristics of retinal degeneration or AMD. The invention also covers the animals produced using these methods, approaches for identifying agents that may inhibit disease characteristics, and potential treatment methods using identified agents.

Another patent, “Diagnostic Methods for Age-Related Macular Degeneration,” describes ways to identify people who have or may be at risk of developing AMD or related diseases associated with oxidation of DHA-containing lipids. The methods include testing bodily fluids for elevated levels of 2-(ω-carboxyethyl) pyrrole (CEP) adducts or antibodies that bind to CEP adducts. The invention also addresses CEP protein and peptide adducts, related antibodies, and diagnostic kits.

Career Highlights

Hollyfield’s patent portfolio reflects a focus on understanding and detecting retinal disease. His work connects experimental animal models with diagnostic approaches that may support research into AMD and the development of potential treatments.

Collaborations

Hollyfield’s listed coworkers include Robert G. Salomon and John W. Crabb. His professional affiliations include Case Western Reserve University and The Cleveland Clinic Foundation.

Conclusion

Joe G. Hollyfield’s inventions address both the study and diagnosis of retinal degeneration, with a particular emphasis on age-related macular degeneration.